AbbVie has delivered a powerful run over the past several years, and the current share price of US$262.51 reflects ...

Wolfe Research upgraded two prominent pharmaceutical companies to Outperform on August 13. The firm upgraded both Biogen Inc.

AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

AbbVie Inc. ABBV shares are edging higher Friday morning following Thursday’s announcement of positive Phase 3 trial results ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alcon (ALC) and AbbVie (ABBV) with bullish sentiments. According to TipRanks.com, England is ranked ...

AbbVie's dividend is a very appealing factor.

Pfizer's 6.4% yield and cheap valuation support a $35 target; Chevron's Hess synergies and Microsoft power deal back $250 by 2027. AbbVie's Skyrizi and Rinvoq each grew over 20% in Q2, driving ...

AbbVie Inc. (ABBV), the North Chicago, Illinois-based Pharma giant, is expected to report its Q1 2026 earnings around April 29th - in just under three weeks' time. A few days ago, AbbVie released an 8 ...